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INTRODUCTION: Primary mucinous adenocarcinoma or mucinous eccrine carcinoma of the skin is a rare
malignant neoplasm showing predilection to the head and neck. Distinguishing between these primary
neoplasms and themore frequent metastatic mucinous deposits on the skin from primaries in the breast
and gastrointestinal tract constitutes a diagnostic dilemma.
PRESENTATIONOF CASE:We report a case of a 61-year-old ladywho presentedwith a slow-growing, pain-
less scalp nodule. Upon excision, it was diagnosed as “primarymucinous adenocarcinoma”. An extensive
work-up in search for another primary tumour failed to show a primary malignancy elsewhere and the
diagnosis of a primary eccrine mucinous adenocarcinoma of the skin was rendered.
DISCUSSION: A review of the literature on this entity is presented, discussing diagnostic challenges and
therapeutic options that of interest to surgeons, pathologists and dermatologists.
CONCLUSION: These tumours are indolent and low-grade, with a tendency for local, sometimes multiple,
recurrences. Proper patient counselling and follow-up are important in treatment. Sound collaboration
between clinicians and pathologists, for good therapeutic results, is of utmost importance.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Mucinous sweat gland carcinoma is a rare malignant tumour
of the skin. We report herein the case of a 61-year-old lady
who presented with a scalp mass. After excision, histopathologi-
cal examination of the mass revealed mucinous adenocarcinoma.
Extensive metastatic work-up, including a total body computed
tomographic andpositron emission scan (PET/CT scan), showed the
neoplasm to be a primary mucinous adenocarcinoma of the skin.
Distinguishing this primary neoplasm from metastatic mucinous
adenocarcinoma originating from other primary sites in particu-
lar from the breast presents a diagnostic dilemma. A review of the
literature of this rare, yet challenging, entity follows.
2. Report of a case
A 61-year-old lady, of Caucasian origin, presented to our care
with a slow growing, painless, spherical, scalp nodule overlying
the right temporal region, measuring 1.5×1 cm. The mass was
∗ Corresponding author. Tel.: +966 502512572; fax: +966 138773695.
E-mail address: osama.albeteddini@gmail.com (O.S.A. Beteddini).
subcutaneous, being tethered to the skin, yetmobilewith respect to
the underlying skull. It was ﬁrm, non-compressible, non-pulsatile
and showed no central punctum. The nodule was present for the
last 5 years with no history of pain, secretions or overlying redness.
Upon examination, no regional lymphadenopathy or abnormal
ﬁndings in the head or neck region could be noticed. The patient
had been medically followed up in the past with regular screening
for breast cancer and gastrointestinal disease, namely colorectal
cancer.
An excisional biopsy of the nodule was done under local anaes-
thesia with no adverse events and the skin defect was primarily
closed. Histopathological examination of the mass showed hair-
bearing skin with underlying lakes of mucin separated by delicate
ﬁbrous septae. Floating in between themucinous lakes were nests,
clusters, and cords of predominantly uniform round to cuboidal
epithelial cells that exhibit mild to moderate nuclear variability.
Focal areas show duct formation. Occasional tumour nests show
prominent proliferation of cells with cribriforming. The tumour
showed no connection to the overlying skin or adnexal structures
(See Fig. 1). The neoplastic cells were strongly positive for cytok-
eratin 7 (CK7) and oestrogen and progesterone receptors. The cells
were negative for cytokeratin 20 (CK20) andHer-2-neu (See Fig. 2).
http://dx.doi.org/10.1016/j.ijscr.2015.02.006
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. A. Low power view of the skin nodule exhibiting skin with underlying lakes of mucin compartmentalised by delicate ﬁbrous septae and ﬂoating nests and ducts
of tumour cells B&C. Higher power showing variability in cellularity and proliferation of neoplastic cells ranging from less cellular nests/ducts to more cellular areas with
cribriforming.
Themorphologic and immunohistochemical featureswere con-
sistent with mucinous adenocarcinoma. As the histopathological
distinction between primary eccrine mucinous adenocarcinoma
and metastatic mucinous tumour is almost impossible, it was rec-
ommended to do a complete workup to exclude the presence of a
primary involving an extracutaneous site, especially the breast.
At this stage, the patient was referred to a cancer cen-
tre. She had an extensive oncological evaluation, including a
detailed clinical assessment and a PET/CT scan, in search of a
possible primary mucinous adenocarcinoma originating mainly
in the breast and gastrointestinal tract, resulting in a negative
metastatic work-up. Therefore, the diagnosis of a primary eccrine
mucinous adenocarcinoma of the scalp was conﬁrmed. She under-
went Moh’s micrographic surgery until negative margins were
obtained. Having no evidence-based data regarding treatment,
follow-up and recurrence rates of this tumour, the patient was
put on a biannual follow-up programme for possible early detec-
tion of local recurrence or metastasis in relation to this unusual
tumour.
3. Discussion
Primary eccrinemucinous adenocarcinomaof the skin is a rarely
described pathological entity. This neoplasm was ﬁrst described
by Lennox et al. [1,2] in 1951, it affects more men than women
in an approximately 2:1 ratio, mostly seen in 5–7th decade with
an average age at occurrence of 61 years (range 8–84 years) [3,4].
There is an increased predilection to white rather than African
American, East Asian or Indian individuals [5,21]. The majority
of these tumours are located in the head and neck; however,
less frequently, they may arise from other areas of the body [6].
More than 50% of reported cases are located in the peri-orbital
region and the hair-bearing scalp [1,7].
Typically, these tumours present as slow growing, painless, soft,
sometimes indurated, reddishor grey-blue, non-ulceratingnodules
that have been present for several years [1,3], with longer courses
for up to 20 years prior to presentation being reported [8]. The pre-
sentation of these neoplasms in the form of ulcers or cysts has also
beendescribed [3]. The tumoursusually range in sizebetween1and
8 cm [4], the mean diameter prior to excision being reported to be
around1.8 cm[21].However, larger variantshavebeendescribed in
literature [4]. The nodules are well circumscribed, unencapsulated,
and often ﬁxed to the dermis making them unable to be “shelled
out”. The cut surface is mostly gelatinous.
These tumours are considered low-grade malignant neoplasms
with an indolent course, having a tendency for local recurrence
(19.6%) and metastasis (6.1%) after surgical treatment over a
mean follow-up period of 37.4 months [21], with most metas-
tases being to the regional lymph nodes [9,10]. Distant metastases
have been reported in 2–7 percent of affected patients [6]. How-
ever, these tumours more frequently invade tissues by direct
extension, due to the presence of satellite islands of tumour cells
present around the main nodule, and via regional lymph node
invasion [11,12]. Death due to mucinous adenocarcinoma of the
skin is exceptional with only less than 5 cases reported thus far,
most associatedwithmultiple tumour recurrences andwidespread
metastatic disease [13].
The clinical presentation of mucinous carcinoma is nonspeciﬁc
and the differential diagnosis includes epidermoid cyst, pyogenic
granuloma,melanoma, sebaceouscyst, sebaceouscarcinoma, cystic
basal cell carcinoma, neuroma, lacrimal sac tumour, haemangioma,
pilomatricoma, lipoma and metastatic adenocarcinoma [5,14].
Histogenesis of this tumour has not been clearly elucidated.
There is strong evidence that these neoplasms arise from eccrine
ducts, however, some studies support that at least a subset of these
tumours to be originating from apocrine ducts [15].
The primary challenge in diagnosis lies in differentiating these
rare primary skin neoplasms of sweat gland origin from the more
frequent mucinous secondary deposits to the skin from primaries
elsewhere. Mucin-producing primary tumours are known to orig-
inate in the breast, gastrointestinal tract, lung, kidney, ovaries,
pancreas and prostate [3,16]. Metastatic lesions from the breast
and colon are most likely to mimic mucinous carcinoma of the
skin, knowing the fact that 19% of men with colon cancer and
6% of women with breast cancer have metastatic skin disease
[14,17]. Differentiating secondary deposits, particularly from these
two sites from primary mucinous skin carcinoma based on mor-
phologic evaluation alone is almost impossible. Therefore, the
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Fig. 2. Immunohistochemistry shows tumour cells to be strongly positive for CK7, oestrogen receptors (ER), and progesterone receptors (PR) and negative for CK 20.
differentiation is mainly based on ﬁrstly, ruling out the pres-
ence of another primary malignant site through a full oncological
evaluation and, secondly, on certain histological and pathological
characteristics of the mucinous lesion.
Histologically, these tumours are generally well circumscribed,
unencapsulated, asymmetric, dermal nodules that may extend to
involve subcutis andevendeeper tissueplanes.Most tumours show
no connection to the overlying epidermis or skin adnexae. Charac-
teristically, there are pools of basophilicmucin compartmentalised
by delicate thin ﬁbrous septae creating a honey comb pattern.
Within these mucinous lakes are small islands, clusters, and/or
tubules of ﬂoating epithelial cells (Fig. 1A). The neoplastic cells
are round to cuboidal with abundant eosinophilic to clear cyto-
plasm, small central nuclei, minimal nuclear pleomorphism, and
only rare mitotic ﬁgures (Fig. 1B&C). These tumour cells are often
grouped in nests and duct-like structures reminiscent of eccrine
and apocrine sweat glands. Someglandular structures showpromi-
nent proliferation and may form a cribriforming pattern. Smaller
tumour satellites may occur around the primary nodule. Epider-
motism by these neoplastic cells is an unusual feature [3,14]. The
presenceof copious amounts ofmucinhasbeenhypothised to serve
as a physical barrier to spread, compressing the tumour stroma and
restricting growth, as well as inhibiting DNA synthesis, decreasing
the rateof angiogenesis [3,16], andconsequentlymetastaticdisease
[9].
Histologic distinction between primary and secondary tumours
may be impossible, albeit the lattermay show certain features sup-
porting metastasis such as less abundance of mucin, larger tumour
clusters and sheetswith predominance ofmalignant epithelial cells
overmucin, and lackofhoney combingdue to theabsenceofﬁbrous
septae in-between the mucinous lakes [18].
Histochemical and immunohistochemical staining can assist in
differentiating tumour types. The tumour cells express cytokeratin
AE1/AE3, epithelial membrane antigen (EMA), and carcinoembry-
onic antigen (CEA) in keeping with its derivation from secretory
lobule. There is strong nuclear staining for oestrogen receptors
and variable but mostly positive staining for progesterone recep-
tors (Fig. 2). The cells are also often positive for alpha-lactalbumin,
salivary amylase, beta-2-microglobulin, cytokeratin CAM 5.2, and
gross cystic disease ﬂuid protein -15 (GCDFP-15). There is variable
expression of S-100 protein. The tumour shows a low prolifera-
tion index by Ki-67. In addition, the cells are negative for CK20,
a helpful feature in distinguishing it from metastasis from pri-
mary gastrointestinal tumours that are often CK20 positive (Fig. 2).
Primary tumours may occasionally show focal neuroendocrine dif-
ferentiation as evidenced by positive reaction by Grimilius, and
positive staining by chromogranin, synaptophysin, and neuron
speciﬁc enolase (NSE) [3,15,18]. Alcian blue staining of primary
skin lesions is positive at a pH of 2.4 but is negative at a pH of
0.4, differentiating them from other sweat gland tumours [14].
The mucin in primary skin lesions is a sialomucin which is resis-
tant to digestion with diastase and hyaluronidase but sensitive to
sialidase [3,16], unlike mucinous lesions from gastrointestinal pri-
maries that contain sulphomucin [14,19]. Moreover, cytokeratin
20 (CK20) is commonly expressed in gastrointestinal neoplasms
but absent in skin primaries. Additionally, the expression of cytok-
eratin 5, 6 and 7 (CK5/6/7) (Fig. 2) and p63 in primary eccrine
carcinoma of the skin (indicating the presence of myoepithelial
cells) can help exclude metastatic mucinous breast carcinoma
[20]. In summary, although helpful, histopathological features
cannot exclude metastatic disease with 100% certainty; there-
fore, the importance of a full metastatic work-up cannot be
overemphasised.
As for treatment, surgical excision of primary eccrine muci-
nous adenocarcinoma of the skin is the therapeutic mainstay in
most cases. Because of the recurring nature of the tumour, ade-
quate excision with wide margins (at least 1 cm) is advocated.
Moh’s micrographic surgery can be a particularly advantageous
treatment modality in this setting. These tumours are generally
resistant to radiotherapy and chemotherapy and these tools are
not usually employed [3,14]. Finally, patients are to be coun-
selled about the importance of frequent follow-up to rule out
local tumour recurrence or the development of regional lym-
phadenopathy. Knowing that younger patient age at presentation,
Asian background, location of the tumour on the trunk, tumours
larger than 1.5 cm and longer follow-up periods are factors that
could be associated with poor outcomes, namely, recurrence and
metastasis [21].
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4. Conclusion
Before a diagnosis of a primary mucinous adenocarcinoma is
established, a primary mucinous carcinoma of breast, gastroin-
testinal tract, or other organs must be excluded as the majority
of cutaneous mucinous carcinoma cases, in fact, represent metas-
tasis. Primary mucinous carcinoma of the skin, in contrast to
other sweat gland carcinomas, is an indolent low-grade malignant
tumour with tendency for local, sometimes multiple, recurrences.
Distant metastasis is rare and is often limited to regional lymph
nodes. Primary eccrinemucinous adenocarcinomaof the skin poses
challenges in relation to its diagnosis and differentiation from
metastatic adenocarcinoma to the skin and with regard to its
treatment. Its rarity precludes comparative evaluation of therapeu-
tic options. However, sound collaboration between clinicians and
pathologists, for a good therapeutic result, is of utmost importance.
Proper patient counselling and follow-up are important in treating
this low-grade, indolent and frequently recurring tumour.
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